- Home
- VALN vs BXC Comparison
VALN vs BXC Comparison
Compare VALN & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- BXC
- Stock Information
- Founded
- VALN 2012
- BXC 2004
- Country
- VALN France
- BXC United States
- Employees
- VALN N/A
- BXC N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- BXC Wholesale Distributors
- Sector
- VALN Health Care
- BXC Consumer Discretionary
- Exchange
- VALN Nasdaq
- BXC Nasdaq
- Market Cap
- VALN 510.7M
- BXC 585.9M
- IPO Year
- VALN 2021
- BXC 2004
- Fundamental
- Price
- VALN $6.40
- BXC $66.79
- Analyst Decision
- VALN Strong Buy
- BXC Strong Buy
- Analyst Count
- VALN 3
- BXC 5
- Target Price
- VALN $15.33
- BXC $115.40
- AVG Volume (30 Days)
- VALN 83.3K
- BXC 82.7K
- Earning Date
- VALN 05-07-2025
- BXC 07-29-2025
- Dividend Yield
- VALN N/A
- BXC N/A
- EPS Growth
- VALN N/A
- BXC N/A
- EPS
- VALN N/A
- BXC 4.53
- Revenue
- VALN $201,099,222.00
- BXC $2,935,514,000.00
- Revenue This Year
- VALN $18.74
- BXC $3.40
- Revenue Next Year
- VALN $29.26
- BXC $5.01
- P/E Ratio
- VALN N/A
- BXC $14.79
- Revenue Growth
- VALN 21.64
- BXC N/A
- 52 Week Low
- VALN $3.62
- BXC $63.55
- 52 Week High
- VALN $9.50
- BXC $134.79
- Technical
- Relative Strength Index (RSI)
- VALN 48.49
- BXC 44.14
- Support Level
- VALN $6.18
- BXC $64.91
- Resistance Level
- VALN $6.54
- BXC $68.71
- Average True Range (ATR)
- VALN 0.21
- BXC 2.24
- MACD
- VALN 0.01
- BXC 0.06
- Stochastic Oscillator
- VALN 54.35
- BXC 17.41
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.